Cargando…

Differentiating biochemical from clinical heparin resistance in COVID-19

Detalles Bibliográficos
Autores principales: Lisman, Ton, Thachil, Jecko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471526/
https://www.ncbi.nlm.nih.gov/pubmed/32880796
http://dx.doi.org/10.1007/s11239-020-02259-5
_version_ 1783578786419179520
author Lisman, Ton
Thachil, Jecko
author_facet Lisman, Ton
Thachil, Jecko
author_sort Lisman, Ton
collection PubMed
description
format Online
Article
Text
id pubmed-7471526
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-74715262020-09-04 Differentiating biochemical from clinical heparin resistance in COVID-19 Lisman, Ton Thachil, Jecko J Thromb Thrombolysis Letter to the Editor Springer US 2020-09-03 2020 /pmc/articles/PMC7471526/ /pubmed/32880796 http://dx.doi.org/10.1007/s11239-020-02259-5 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Lisman, Ton
Thachil, Jecko
Differentiating biochemical from clinical heparin resistance in COVID-19
title Differentiating biochemical from clinical heparin resistance in COVID-19
title_full Differentiating biochemical from clinical heparin resistance in COVID-19
title_fullStr Differentiating biochemical from clinical heparin resistance in COVID-19
title_full_unstemmed Differentiating biochemical from clinical heparin resistance in COVID-19
title_short Differentiating biochemical from clinical heparin resistance in COVID-19
title_sort differentiating biochemical from clinical heparin resistance in covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471526/
https://www.ncbi.nlm.nih.gov/pubmed/32880796
http://dx.doi.org/10.1007/s11239-020-02259-5
work_keys_str_mv AT lismanton differentiatingbiochemicalfromclinicalheparinresistanceincovid19
AT thachiljecko differentiatingbiochemicalfromclinicalheparinresistanceincovid19